Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-10 4:05 pm Sale | 13G | Salarius Pharmaceuticals, Inc. SLRX | Sio Capital Management, LLC | 1,354,291 3% | -302,951![]() (-18.28%) | View |
2022-02-10 4:02 pm Sale | 13G | Cellectar Biosciences, Inc. CLRB | Sio Capital Management, LLC | 0 0% | -2,331,123![]() (Position Closed) | View |
2022-02-10 4:01 pm Sale | 13G | Curis, Inc. CRIS | Sio Capital Management, LLC | 3,866,645 4.22% | -889,793![]() (-18.71%) | View |
2021-02-16 1:03 pm Purchase | 13G | Cellectar Biosciences, Inc. CLRB | Sio Capital Management, LLC | 2,331,123 8.69% | 2,331,123![]() (New Position) | View |
2021-02-16 1:03 pm Purchase | 13G | Curis, Inc. CRIS | Sio Capital Management, LLC | 4,756,438 5.78% | 4,756,438![]() (New Position) | View |
2021-02-16 1:03 pm Purchase | 13G | Larimar Therapeutics, Inc. LRMR | Sio Capital Management, LLC | 188,661 1.23% | 188,661![]() (New Position) | View |
2021-02-16 1:03 pm Purchase | 13G | Salarius Pharmaceuticals, Inc. SLRX | Sio Capital Management, LLC | 1,657,242 8.35% | 1,657,242![]() (New Position) | View |
2020-02-14 4:00 pm Sale | 13G | Achieve Life Sciences, Inc. ACHV | Sio Capital Management, LLC | 0 0% | -597,373![]() (Position Closed) | View |
2020-02-14 4:00 pm Unchanged | 13G | Fresh Tracks Therapeutics, Inc. FRTX | Sio Capital Management, LLC | 0 0% | 0 (Unchanged) | View |
2020-02-14 4:00 pm Purchase | 13G | Bionano Genomics, Inc. BNGO | Sio Capital Management, LLC | 1,210,821 4.57% | 495,979![]() (+69.38%) | View |
2020-02-14 4:00 pm Purchase | 13G | Trillium Therapeutics Inc. TRIL | Sio Capital Management, LLC | 2,751,186 9.81% | 2,751,186![]() (New Position) | View |
2020-02-14 4:00 pm Purchase | 13G | Larimar Therapeutics, Inc. LRMR | Sio Capital Management, LLC | 2,283,164 6.11% | 2,283,164![]() (New Position) | View |
2019-02-14 5:05 pm Purchase | 13G | Achieve Life Sciences, Inc. ACHV | Sio Capital Management, LLC | 597,373 8.89% | 597,373![]() (New Position) | View |
2019-02-14 5:05 pm Purchase | 13G | Bionano Genomics, Inc. BNGO | Sio Capital Management, LLC | 714,842 7.13% | 714,842![]() (New Position) | View |
2019-02-14 5:04 pm Purchase | 13G | Fresh Tracks Therapeutics, Inc. FRTX | Sio Capital Management, LLC | 1,615,887 7.41% | 1,615,887![]() (New Position) | View |
2018-02-14 4:02 pm Purchase | 13G | Catalyst Biosciences, Inc. CBIO | Sio Capital Management, LLC | 202,281 3.48% | 34,281![]() (+20.41%) | View |
2018-02-14 4:01 pm Sale | 13G | Quotient Limited QTNT | Sio Capital Management, LLC | 1,426,125 3.13% | -811,646![]() (-36.27%) | View |